PELLICANO, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 2.193
NA - Nord America 2.174
EU - Europa 1.180
SA - Sud America 336
AF - Africa 97
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.987
Nazione #
US - Stati Uniti d'America 2.106
SG - Singapore 879
IT - Italia 544
VN - Vietnam 339
HK - Hong Kong 296
BR - Brasile 276
CN - Cina 268
DE - Germania 147
IN - India 124
FR - Francia 93
SE - Svezia 86
BD - Bangladesh 83
FI - Finlandia 77
RU - Federazione Russa 52
GB - Regno Unito 45
CA - Canada 41
IQ - Iraq 31
KR - Corea 31
JP - Giappone 30
ID - Indonesia 28
MA - Marocco 24
ZA - Sudafrica 24
AR - Argentina 22
NL - Olanda 17
AT - Austria 14
PL - Polonia 14
BG - Bulgaria 13
EC - Ecuador 12
UA - Ucraina 11
LT - Lituania 10
MX - Messico 10
PH - Filippine 10
PK - Pakistan 10
CI - Costa d'Avorio 9
IE - Irlanda 8
UY - Uruguay 8
VE - Venezuela 8
EG - Egitto 7
KE - Kenya 7
NP - Nepal 7
TR - Turchia 7
BE - Belgio 6
ES - Italia 6
AU - Australia 5
MK - Macedonia 5
MY - Malesia 5
TG - Togo 5
UZ - Uzbekistan 5
CO - Colombia 4
CZ - Repubblica Ceca 4
JO - Giordania 4
OM - Oman 4
PT - Portogallo 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
IL - Israele 3
LB - Libano 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
NI - Nicaragua 2
PY - Paraguay 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
Totale 5.976
Città #
Singapore 513
San Jose 318
Ashburn 312
Hong Kong 281
Rome 223
Santa Clara 128
Los Angeles 107
Ho Chi Minh City 102
Hanoi 91
Chandler 84
Dallas 72
Hillsboro 70
Fairfield 69
Munich 59
New York 56
Beijing 55
Lauterbourg 52
Frankfurt am Main 47
Buffalo 45
Boardman 44
Hefei 32
Turku 32
Milan 30
Wilmington 30
Redondo Beach 29
Houston 27
São Paulo 27
The Dalles 27
Cambridge 26
Tokyo 25
Woodbridge 24
Council Bluffs 23
Lappeenranta 23
Princeton 23
Seattle 23
Helsinki 22
Casablanca 21
Millbury 19
San Paolo di Civitate 19
Cosenza 18
Jakarta 17
Naples 17
Nuremberg 17
Toronto 17
Johannesburg 16
Boston 15
Da Nang 15
Haiphong 15
London 15
Moscow 15
Seoul 15
Chicago 13
Lawrence 13
Baghdad 12
Bengaluru 12
San Diego 12
Chennai 11
Sofia 11
Brooklyn 10
Montreal 10
Paris 10
Rocca d'Evandro 10
Abidjan 9
Andover 9
Dhaka 9
Ann Arbor 8
Atlanta 8
Biên Hòa 8
Bologna 8
Warsaw 8
Dublin 7
Falkenstein 7
Orem 7
Porto Alegre 7
San Francisco 7
Belo Horizonte 6
Elk Grove Village 6
Hyderabad 6
Montevideo 6
Nairobi 6
Bari 5
Catania 5
Clementon 5
Erbil 5
Guangzhou 5
Guayaquil 5
Hải Dương 5
Kathmandu 5
Lomé 5
Mugnano di Napoli 5
Padova 5
Phoenix 5
Salt Lake City 5
Shanghai 5
Stockholm 5
Vienna 5
Amman 4
Can Tho 4
Ciampino 4
Curitiba 4
Totale 3.754
Nome #
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis 154
Contrast-Induced Acute Kidney Injury and Endothelial Dysfunction: The Role of Vascular and Biochemical Parameters 152
Comparisons of skin microvascular changes in patients with primary aldosteronism and essential hypertension 147
CD21low B cells in systemic sclerosis: a possible marker of vascular complications 143
Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis 142
CD21 low B cells are predictive markers of new digital ulcers in systemic sclerosis 140
Might IgA be a biomarker of disease activity in Takayasu arteritis 134
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis 127
Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes? 123
Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis 122
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study 122
Effect of secondary infections on the outcomes of patients with hematological malignancies and SARS-CoV-2 infection results from the HM-COV 3.0 study 122
Increased complement activation in systemic sclerosis patients with skin and lung fibrosis 122
Assessment of kidney involvement in systemic sclerosis: from scleroderma renal crisis to subclinical renal vasculopathy 119
Renal parenchymal thickness is both related to vascular endothelial growth factor and intrarenal stiffness in systemic sclerosis 116
Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis 115
In systemic sclerosis {TAPSE}/{sPAP} ratio can be used in addition to the {DETECT} algorithm for pulmonary arterial hypertension diagnosis 115
Chest wall muscle area, ventilatory efficiency and exercise capacity in systemic sclerosis 113
The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease 112
Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study 106
Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease. the role of resistive index 105
SERUM LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP) IS ASSOCIATED WITH DIGITAL ULCERS (DUS) IN SYSTEMIC SCLEROSIS (SSC) PATIENTS 104
Covid-19 infection in autosomal dominant polycystic kidney disease and chronic kidney disease patients. progression of kidney disease 103
CHEST WALL MUSCLE AREA AND EXERCISE CAPACITY IN SYSTEMIC SCLEROSIS 100
Recurrent angioedema: occurrence, features, and concomitant diseases in an Italian single-center study 98
Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly 98
Phase angle, nutritional status, and mortality in systemic sclerosis. An exploratory pilot study 97
In systemic sclerosis patients the anxiety disorder and raynaud’s phenomenon are increased during lock down period for COVID-19 pandemic 94
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients 94
Color doppler ultrasonography of digital arteries and digital ulcers development in systemic sclerosis 93
Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis 93
Skin perfusion of hands is associated with parasympathetic activity in systemic sclerosis 92
Role of kinurenic acid in the systemic sclerosis renal involvement 91
The effect of SARS-CoV-2 vaccination on B-cell phenotype in systemic sclerosis patients 91
In acromegalic patients the serum levels of interleukin-33 and Resolvin D1 influence skin perfusion of hands: A pilot study 88
Headache characteristics in acromegaly. Only a secondary disorder? 88
Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts 88
In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET 86
Serum adiponectin, a novel biomarker correlates with skin thickness in systemic sclerosis 84
Serum immunoglobulin G (IgG) subclasses in a cohort of systemic sclerosis patients 84
IL33 and sST2 serum level in systemic sclerosis microvascular involvement 84
IN SYSTEMIC SCLEROSIS (SSC) PATIENTS, PERIPHERAL BLOOD CD21LOW B CELLS INFLUENCE JOINTS INVOLVEMENT 84
Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement 83
Diffusing capacity of the lungs for carbon monoxide and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of patients with systemic sclerosis 82
Serum and urine free light chains measurements in patients with systemic sclerosis. novel biomarkers for disease activity 81
GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis. A retrospective study 79
Tubular changes in autosomal dominant polycystic kidney disease patients. observational study 79
Kidney dysfunction is associated with adverse outcomes in internal medicine COVID-19 hospitalized patients 78
Changes in renal microcirculation in patients with nephrotic and nephritic syndrome. the role of resistive index 74
ILOPROST INFUSION REDUCES NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) SERUM LEVELS IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 74
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study 72
Serum kynurenic acid is lower in systemic sclerosis patients with microvascular damage of hands 71
Resistant hypertension and related outcomes in a cohort of patients with cardiorenal multimorbidity hospitalized in an internal medicine ward 69
Nephroangiosclerosis not related to hypertension: a matter to resolve in the era of precision medicine 67
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort 66
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients 60
In systemic sclerosis patients, peripheral blood CD21low B cells and serum IL-4 and IL-21 influence joint involvement 55
Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities 55
Thymic stromal lymphopoietin and digital microvascular damage in systemic sclerosis patient. a pilot study 55
Tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio and cardiorenal syndrome type 2 in the systemic sclerosis EUSTAR cohort 54
Type 2 cytokines and scleroderma interstitial lung disease 52
Renal Involvement in Mixed Cryoglobulinemic Vasculitis: Current Perspectives 51
Metabolic syndrome and cardiovascular-kidney-metabolic health: Evaluation of predictive risk factor for mortality in systemic sclerosis 49
Serum Uric Acid/Serum Creatinine Ratio and Chronic Vascular Lesions on Renal Biopsy: A Retrospective Observational Study 46
Serum-soluble ST2 and systemic sclerosis arthropathy 45
Serum Calprotectin as a Novel Biomarker of Disease Severity and Activity in Systemic Sclerosis Patients 43
Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss 39
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 38
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients 32
Assessment of Triglyceride/High-Density Lipoprotein Cholesterol Ratio and Triglyceride-Glucose Index Threshold in Patients with Chronic Kidney Disease: Evaluation of Clinical Features and Outcomes 7
null 5
Clinical outcomes in patients with cardiorenal multimorbidity: the role of serum uric acid/serum creatinine ratio 5
The Role of Serum Uric Acid and Serum Creatinine Ratio as Possible Markers of Autonomic Dysfunction and Left Ventricular Mass Index in Atherosclerotic Renal Artery Stenosis 5
Accuracy of glomerular filtration rate estimating equations in systemic sclerosis 4
null 3
Thymic stromal lymphopoietin in systemic sclerosis interstitial lung disease: a pilot study 3
Totale 6.266
Categoria #
all - tutte 19.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 4 4
2021/2022215 31 6 9 5 19 8 3 11 30 14 40 39
2022/2023372 51 56 11 35 41 29 30 29 34 7 31 18
2023/2024447 9 67 25 41 31 87 34 17 6 27 46 57
2024/20251.500 37 119 50 86 148 108 63 30 212 117 148 382
2025/20263.522 407 265 301 289 457 158 539 145 337 355 269 0
Totale 6.266